Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
567 studies found for:    glioma | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
glioma | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Conditions: Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
Interventions: Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
2 Recruiting Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
Condition: Glioma
Intervention: Procedure: Detecting of Biological Borders of Gliomas
3 Unknown  Gene Expression, Immunological Status and Metabolome in Glioma Patients
Condition: Glioma
Interventions: Procedure: Glioma resection;   Other: Blood sampling
4 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
5 Recruiting Brain Glioma Registry Combining Clinical and Imaging Information
Condition: Adult Glioma
Intervention: Other: Brain Glioma Registry
6 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma.;   Newly Diagnosed Pediatric High Grade Glioma.;   Recurrent Pediatric High Grade Glioma.;   Recurrent Pediatric Low Grade Glioma.
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
7 Recruiting Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Conditions: Oligodendroglioma;   Astrocytoma, Grade II;   Glioma, Astrocytic;   Glioma;   Malignant Glioma;   Oligoastrocytoma, Mixed
Interventions: Biological: GBM6-AD and poly-ICLC before and after surgery;   Biological: GBM6-AD and poly-ICLC after surgery only
8 Recruiting Case-cohort Study of Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma
Condition: Glioma
Interventions: Drug: Midazolam;   Drug: propofol;   Drug: Dexmedetomidine
9 Not yet recruiting Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
Condition: Recurrent High-grade Glioma
Interventions: Drug: Ultra-low dose Bevacizumab;   Drug: Temozolomide
10 Recruiting 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
Conditions: Glioma;   Breast Cancer
Intervention: Radiation: 68Ga-NOTA-NFB
11 Not yet recruiting A Phase II Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Condition: Glioma
Interventions: Device: NovoTTF-200A;   Drug: Temozolomide
12 Recruiting Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Conditions: Cholangiocarcinoma;   Chondrosarcoma;   Glioma;   Other Advanced Solid Tumors
Intervention: Drug: AG-120
13 Recruiting Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Conditions: Diffuse Intrinsic Pontine Glioma;   Brainstem Glioma
14 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation
15 Recruiting Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Conditions: Brain Tumor;   Glioblastoma;   Anaplastic Glioma
Interventions: Drug: everolimus;   Drug: sorafenib
16 Not yet recruiting A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Conditions: Glioma;   Malignant Glioma;   Astrocytoma, Grade II;   Oligodendroglioma;   Glioma, Astrocytic;   Oligoastrocytoma, Mixed
Interventions: Biological: IMA950;   Biological: poly-ICLC;   Biological: Varlilumab
17 Unknown  Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Conditions: Epilepsy;   Glioma
18 Recruiting Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Conditions: Cholangiocarcinoma;   Chondrosarcoma;   Glioma
Intervention: Drug: AG881
19 Recruiting Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
Conditions: Low Grade Glioma;   Malignant Glioma
20 Recruiting Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years